Role of miRNAs in the progression of malignant melanoma
- PMID: 19638982
- PMCID: PMC2736818
- DOI: 10.1038/sj.bjc.6605204
Role of miRNAs in the progression of malignant melanoma
Abstract
Analysis of microRNA (miRNA) biogenesis and function is an area of research that started only recently but has subsequently accelerated tremendously. This is because of the impressive impact of miRNA-mediated gene regulation and the obvious potential of those tiny RNA molecules in future diagnostic and therapeutic applications. In this review, recent progress to reveal the role of miRNAs in the tumourigenesis of malignant melanoma, as well as future prospects of melanoma-related miRNA research, will be addressed.
Figures


Similar articles
-
Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.Pigment Cell Melanoma Res. 2012 Nov;25(6):740-57. doi: 10.1111/pcmr.12018. Pigment Cell Melanoma Res. 2012. PMID: 22958787 Review.
-
miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.J Invest Dermatol. 2009 Jul;129(7):1740-51. doi: 10.1038/jid.2008.452. Epub 2009 Feb 12. J Invest Dermatol. 2009. PMID: 19212343
-
Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31. Cell Tissue Res. 2013. PMID: 23111773
-
MicroRNA-sequencing data analyzing melanoma development and progression.Exp Mol Pathol. 2018 Dec;105(3):371-379. doi: 10.1016/j.yexmp.2018.11.001. Epub 2018 Nov 8. Exp Mol Pathol. 2018. PMID: 30414979
-
MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.J Cell Physiol. 2018 Jul;233(7):5133-5141. doi: 10.1002/jcp.26395. Epub 2018 Jan 19. J Cell Physiol. 2018. PMID: 29226953 Review.
Cited by
-
Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review).Oncol Lett. 2013 Aug;6(2):295-305. doi: 10.3892/ol.2013.1405. Epub 2013 Jun 17. Oncol Lett. 2013. PMID: 24137320 Free PMC article.
-
miRTrail--a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases.BMC Bioinformatics. 2012 Feb 22;13:36. doi: 10.1186/1471-2105-13-36. BMC Bioinformatics. 2012. PMID: 22356618 Free PMC article.
-
LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.Am J Cancer Res. 2017 Dec 1;7(12):2526-2535. eCollection 2017. Am J Cancer Res. 2017. PMID: 29312805 Free PMC article.
-
miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6.Exp Mol Med. 2014 Oct 3;46(10):e116. doi: 10.1038/emm.2014.63. Exp Mol Med. 2014. PMID: 25277211 Free PMC article.
-
MicroRNA-204/211 alters epithelial physiology.FASEB J. 2010 May;24(5):1552-71. doi: 10.1096/fj.08-125856. Epub 2010 Jan 7. FASEB J. 2010. PMID: 20056717 Free PMC article.
References
-
- Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, Robinson WA (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68: 1362–1368 - PubMed
-
- Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149–D153 - PMC - PubMed
-
- Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z, Liu CG, Reinhold W, Lorenzi PL, Kaldjian EP, Croce CM, Weinstein JN, Sadee W (2007) MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483–1491 - PubMed
-
- Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452: 896–899 - PubMed
-
- Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C, Care A (2008a) The promyelocytic leukemia zinc finger-microRNA-221/−222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68: 2745–2754 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical